GRI BIO, Inc. Reports Director/Officer Changes
Ticker: GRI · Form: 8-K · Filed: Jun 18, 2024 · CIK: 1824293
Sentiment: neutral
Topics: management-change, corporate-governance, filing
TL;DR
GRI BIO shuffled its board and execs, filed 8-K on 6/17.
AI Summary
GRI BIO, Inc. (formerly Vallon Pharmaceuticals, Inc.) filed an 8-K on June 17, 2024, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The company, incorporated in Delaware, is located in La Jolla, CA, and operates in the Pharmaceutical Preparations sector.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in leadership and officer appointments can introduce uncertainty regarding future company direction and performance.
Key Numbers
- 001-40034 — SEC File Number (Identifies the company's filing history with the SEC.)
- 82-4369909 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- GRI BIO, Inc. (company) — Registrant
- Vallon Pharmaceuticals, Inc. (company) — Former company name
- June 17, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- La Jolla, CA (location) — Principal executive offices address
FAQ
What specific changes were made to the board of directors and officer appointments?
The filing indicates a reportable event concerning the departure of directors, election of directors, and appointment of certain officers, along with compensatory arrangements.
When was the name of the company officially changed?
The former company name was Vallon Pharmaceuticals, Inc., and the date of the name change was September 10, 2020.
What is GRI BIO, Inc.'s primary business sector?
GRI BIO, Inc. is classified under the Pharmaceutical Preparations sector (SIC code 2834).
Where are GRI BIO, Inc.'s principal executive offices located?
The principal executive offices are located at 2223 Avenida de la Playa, Suite 208, La Jolla, CA 92037.
What is the significance of the filing date and the date of the earliest event reported?
The filing was made on June 18, 2024, and the earliest event reported occurred on June 17, 2024, indicating timely reporting of significant corporate actions.
Filing Stats: 657 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2024-06-18 16:48:10
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share GRI The Nasdaq Capital Mark
- $325,000 — r. Agro's current annual base salary of $325,000 has been reduced to $100,000 and he is
- $100,000 — salary of $325,000 has been reduced to $100,000 and he is no longer eligible for an ann
Filing Documents
- val-20240617.htm (8-K) — 25KB
- exhibit101_agroagreement.htm (EX-10.1) — 10KB
- val-20240617_g1.jpg (GRAPHIC) — 16KB
- val-20240617_g2.jpg (GRAPHIC) — 2KB
- 0001824293-24-000070.txt ( ) — 190KB
- val-20240617.xsd (EX-101.SCH) — 2KB
- val-20240617_lab.xml (EX-101.LAB) — 22KB
- val-20240617_pre.xml (EX-101.PRE) — 13KB
- val-20240617_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1# Amendment No. 1 to Employment Agreement, dated June 17, 2024, between the Company and Albert Agro, Ph.D. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). # Indicates a management contract or any compensatory plan, contract or arrangement
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 18, 2024 GRI Bio, Inc. By: /s/ Leanne Kelly Leanne Kelly Chief Financial Officer